Vasculitis - Vaskulitehttps://en.wikipedia.org/wiki/Vasculitis
Vaskulite (Vasculitis) huwa grupp ta' disturbi li jeqirdu l-vini tad-demm (blood vessels) permezz ta' infjammazzjoni. Vaskulite tista' tiġi kklassifikata mill-kawża, il-post, it-tip ta' vina jew id-daqs tal-vina. Testijiet tal-laboratorju u bijopsija tal-ġilda jistgħu jkunu meħtieġa biex jinstabu kawżi sottostanti. It-trattamenti huma ġeneralment diretti lejn il-waqfien tal-infjammazzjoni u s-soppressjoni tas-sistema immuni. Tipikament, jintużaw kortikosterojdi bħal prednisone.

○ Dijanjosi
Vaskulite limitata għall-ġilda tista' titjieb maż-żmien. Madankollu, testijiet tad-demm u tal-awrina jistgħu jsiru biex jinstabu disturbi sistemiċi jew awtoimmuni.

○ Trattament - Drogi OTC
Jekk vaskulite hija limitata għall-ġilda mingħajr invażjoni ta' organi oħra, jista' jintuża ġel sterojdi (steroid ointment). #OTC steroid ointment
☆ AI Dermatology — Free Service
Fir-riżultati ta' Stiftung Warentest tal-2022 mill-Ġermanja, is-sodisfazzjon tal-konsumatur b'ModelDerm kien biss ftit inqas milli b'konsultazzjonijiet bit-telemediċina mħallsa.
  • Disturbi sistemiċi oħra (mard awtoimmuni) li jinvolvu vaskulite għandhom jiġu esklużi.
  • Din hija stampa tipika tal‑vaskulite tar‑riġel. Jista’ jsir test tal‑awrina biex jiċċekkja għal anormalitajiet fil‑funzjoni tal‑kliewi.
  • Livedo vadculopathy
  • Purpura
  • purpura Henoch‑Schönlein (Henoch‑Schönlein purpura)
References An aetiological & clinicopathological study on cutaneous vasculitis 22382191 
NIH
Of the 61 patients studied, hypersensitivity vasculitis (HSV) [23 (37.7%)] and Henoch Schonlein purpura (HSP) [16 (26.2%)] were the two most common forms. Systemic involvement was seen in 32 (52.45%) patients. Drugs were implicated in 12 (19.7%) cases, infections in 7 (11.4%) and connective tissue disorders in 4 (6.5%) cases. No association was seen between history of drug intake and tissue eosinophilia and also between histologically severe vasculitis and clinical severity.
 Leukocytoclastic Vasculitis 29489227 
NIH
Leukocytoclastic vasculitis hija tip ta 'infjammazzjoni tal-ġilda li taffettwa vini tad-demm żgħar fis-saffi fondi tal-ġilda. Jista 'jiġri għall-ebda raġuni magħrufa jew ikun marbut ma' infezzjonijiet, tumuri, mard awtoimmuni, jew mediċini. Sinjali tipiċi jinkludu tikek ħomor jew vjola fuq ir-riġlejn, involviment ta 'bastimenti żgħar, u f'madwar 30 fil-mija tal-każijiet, partijiet oħra tal-ġisem huma affettwati wkoll. Ħafna mill-każijiet jiċċaraw waħedhom fi żmien ftit ġimgħat sa xhur. It-trattament ivarja skont kemm ikun sever, minn tnaqqis gradwali tal-kortikosterojdi orali għall-użu ta 'mediċini oħra li jbaxxu l-infjammazzjoni mingħajr sterojdi.
Leukocytoclastic vasculitis is a cutaneous, small-vessel vasculitis of the dermal capillaries and venules. This condition can be idiopathic or can be associated with infections, neoplasms, autoimmune disorders, and drugs. Key clinical features of leukocytoclastic vasculitis include palpable purpura on the lower extremity, small vessel involvement, and, in about 30 percent of individuals, extracutaneous involvement. Most cases of idiopathic cutaneous, small vessel vasculitis are self-limited with 90 percent of cases resolving in weeks to months of onset. Otherwise, treatment depends on the severity of disease and can range from an oral corticosteroid taper to various steroid-sparing immunosuppressive agents.